A survey for Actual Usage of Tocilizumab in Adult Still's Disease Using a Japanese Healthcare Database
Not Applicable
- Conditions
- Adult Still's Disease
- Registration Number
- JPRN-UMIN000045677
- Lead Sponsor
- CHUGAI PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 193
Inclusion Criteria
Not provided
Exclusion Criteria
Cohort 2 Patients treated with tocilizumab in the past 6 months.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of less than 5mg/day of corticosteroid dosage after 1 year tocilizumab administration
- Secondary Outcome Measures
Name Time Method Analysis of treatment patterns, etc.